Vontobel Holding
SRPT icon

Vontobel Holding’s Sarepta Therapeutics SRPT Stock Holding History

Vontobel Holding’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,710
Closed -$208K – 1155
2024
Q4 		$208K Sell
1,710
-93
-5% -$11.4K ﹤0.01% 1006
2024
Q3 		$225K Sell
1,803
-3,281
-65% -$454K ﹤0.01% 983
2024
Q2 		$803K Sell
5,084
-19,316
-79% -$2.48M ﹤0.01% 625
2024
Q1 		$3.16M Sell
24,400
-878
-3% -$108K 0.03% 378
2023
Q4 		$2.44M Buy
25,278
+2,863
+13% +$275K 0.02% 403
2023
Q3 		$2.72M Sell
22,415
-798
-3% -$90.2K 0.03% 375
2023
Q2 		$2.66M Sell
23,213
-3,898
-14% -$503K 0.02% 392
2023
Q1 		$3.74M Sell
27,111
-1,555
-5% -$202K 0.03% 325
2022
Q4 		$3.62M Buy
28,666
+7,899
+38% +$915K 0.04% 332
2022
Q3 		$2.3M Buy
20,767
+1,638
+9% +$165K 0.03% 375
2022
Q2 		$1.47M Sell
19,129
-250
-1% -$18.4K 0.02% 447
2022
Q1 		$1.51M Sell
19,379
-1,156
-6% -$88.5K 0.01% 497
2021
Q4 		$1.85M Buy
20,535
+3,165
+18% +$271K 0.02% 461
2021
Q3 		$1.61M Buy
17,370
+1,064
+7% +$82K 0.01% 494
2021
Q2 		$1.27M Buy
16,306
+4,007
+33% +$304K 0.01% 542
2021
Q1 		$917K Sell
12,299
-164
-1% -$15.1K 0.01% 547
2020
Q4 		$1.19M Buy
+12,463
New +$1.85M 0.01% 505

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vontobel Holding's SRPT Position: Q1 2025 in Review

Vontobel Holding sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 1,710 shares — an estimated $208K sold.

Vontobel Holding first reported a position in SRPT in Q4 2020 and held it in 17 quarters. The position peaked at $3.74M in Q1 2023. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Vontobel Holding reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 1,710 Sarepta Therapeutics shares in Q1 2025, an estimated $208K.
  • Vontobel Holding first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 17 quarters.
  • Vontobel Holding's Sarepta Therapeutics position peaked at $3.74M in Q1 2023.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.